The Biological Basis of the Merlin CP-GEP Assay: Integrin Signaling and Early Metastatic Competence in Cutaneous Melanoma
{{output}}
The recent inclusion of the Merlin clinicopathologic-gene expression profile (CP-GEP) assay in the National Comprehensive Cancer Network (NCCN) Melanoma Guidelines represents an important milestone in the clinical integration of molecular testing for cutaneous... ...
